Attending #VAM24 this week? Join our Vascular Live Session to get the inside scoop as Dr. Michael Siah shares his experience with the new #PeripheralIVL catheter, #ShockwaveE8, on Thursday 6/20 at 1PM. See you there! US Rx only. ISI http://bit.ly/3iEq7fC @VascularSVS
Shockwave Medical’s Post
More Relevant Posts
-
The controversy of Endotension after Aortic Aneurysm Endovascular Repair (EVAR). SPECT/CT will probably be a usefull tool for diagnosis and treatment guiding. Here is our preliminary experience. A larger multicentric study is coming! https://lnkd.in/ePN4YAcA #EVAR #Aneurysm #AortaEd
To view or add a comment, sign in
-
-
The #SMARTtrial 1-year outcomes uncover that Evolut™ #TAVR delivers superior valve performance vs. SAPIEN™* platform in women with small annuli.¹ Explore the evidence: https://bit.ly/3wymm4S Risk Info: https://bit.ly/4aatMct TAVR risks may include, but are not limited to, death, stroke, damage to the arteries, bleeding, and need for permanent pacemaker. 1. Herrmann H, et al. Self-expanding Versus Balloon-expandable Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annuli: Primary Outcomes From the Randomized SMART Trial. Presented at ACC: April 2024.
To view or add a comment, sign in
-
Early echocardiographic results of patients undergoing #TAVR with the new-generation SAPIEN 3 Ultra Resilia balloon-expandable #THV show superior hemodynamic performance compared to the SAPIEN 3 device. 📑 Read more on #CRTonline. https://ow.ly/qcCI50Q9eV3
New-Generation SAPIEN 3 Ultra Resilia Shows Superior Post-TAVR Hemodynamics to SAPIEN 3 – OCEAN-TAVI Registry Analysis
crtonline.org
To view or add a comment, sign in
-
Did you know Elekta linacs enable exquisite dose shaping for every patient, including large, complex, multi-target head and neck cases? They do this with dynamic jaw tracking, 1mm resolution across a 40x40 field and advanced interdigitation. Find out how ➡️ https://bit.ly/44NW9v9 #WorldHeadandNeckCancerDay #radonc #hncsm
To view or add a comment, sign in
-
Philips Dynamic Coronary Roadmap is a technology that supports navigation through coronary arteries by utilizing a pre-acquired angiogram for a live motion-compensated overlay. This technology significantly reduces the need for contrast media during the navigation of wires and other interventional devices.
Philips Dynamic Coronary Roadmap is a technology that supports navigation through coronary arteries by utilizing a pre-acquired angiogram for a live motion-compensated overlay. This technology significantly reduces the need for contrast media during the navigation of wires and other interventional devices.
To view or add a comment, sign in
-
The #SMARTtrial reveals that Evolut™ #TAVR delivers 5x less bioprosthetic valve dysfunction (BVD) in women vs. SAPIEN platform at 1 year.¹ Explore the evidence: https://bit.ly/4aryVhk Risk Info: https://bit.ly/49AjEJz TAVR risks may include, but are not limited to, death, stroke, damage to the arteries, bleeding, and need for permanent pacemaker. 1. Herrmann H, et al. Self-expanding Versus Balloon-expandable Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annuli: Primary Outcomes From the Randomized SMART Trial. Presented at ACC: April 2024.
See How the SMART Trial Makes a Difference for Women
medtronic.com
To view or add a comment, sign in
-
Philips Dynamic Coronary Roadmap is a technology that supports navigation through coronary arteries by utilizing a pre-acquired angiogram for a live motion-compensated overlay. This technology significantly reduces the need for contrast media during the navigation of wires and other interventional devices.
To view or add a comment, sign in
-
The #SMARTtrial reveals that Evolut™ #TAVR delivers 5x less bioprosthetic valve dysfunction (BVD) in women vs. SAPIEN™* platform at 1 year.¹ Explore the evidence: https://bit.ly/3QClH9n Risk Info: https://bit.ly/3WyhSWv TAVR risks may include, but are not limited to, death, stroke, damage to the arteries, bleeding, and need for permanent pacemaker. 1. Herrmann H, et al. Self-expanding Versus Balloon-expandable Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annuli: Primary Outcomes From the Randomized SMART Trial. Presented at ACC: April 2024
TAVR - SMART Trial
medtronic.com
To view or add a comment, sign in